-
1
-
-
46749113388
-
GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects
-
Brunetti-Pierri N., Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab 2008, 94:391-396.
-
(2008)
Mol Genet Metab
, vol.94
, pp. 391-396
-
-
Brunetti-Pierri, N.1
Scaglia, F.2
-
2
-
-
33751312489
-
Neuroimaging findings in infantile GM1 gangliosidosis
-
Erol I., Alehan F., Pourbagher M.A., et al. Neuroimaging findings in infantile GM1 gangliosidosis. Eur J Paediatr Neurol 2006, 10:245-248.
-
(2006)
Eur J Paediatr Neurol
, vol.10
, pp. 245-248
-
-
Erol, I.1
Alehan, F.2
Pourbagher, M.A.3
-
4
-
-
20844457438
-
The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis
-
Frey L.C., Ringel S.P., Filley C.M. The natural history of cognitive dysfunction in late-onset GM2 gangliosidosis. Arch Neurol 2005, 62:989-994.
-
(2005)
Arch Neurol
, vol.62
, pp. 989-994
-
-
Frey, L.C.1
Ringel, S.P.2
Filley, C.M.3
-
5
-
-
34547920414
-
Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis
-
Gort L., Santamaria R., Grinberg D., et al. Identification of a novel pseudodeficiency allele in the GLB1 gene in a carrier of GM1 gangliosidosis. Clin Genet 2007, 72:109-111.
-
(2007)
Clin Genet
, vol.72
, pp. 109-111
-
-
Gort, L.1
Santamaria, R.2
Grinberg, D.3
-
6
-
-
79959689098
-
Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
-
Higaki K., Li L., Bahrudin U., et al. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency. Hum Mutat 2011, 32:843-852.
-
(2011)
Hum Mutat
, vol.32
, pp. 843-852
-
-
Higaki, K.1
Li, L.2
Bahrudin, U.3
-
7
-
-
33750944986
-
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported
-
Maegawa G.H., Stockley T., Tropak M., et al. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported. Pediatrics 2006, 118:e1550-e1562.
-
(2006)
Pediatrics
, vol.118
-
-
Maegawa, G.H.1
Stockley, T.2
Tropak, M.3
-
8
-
-
84897956543
-
Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up
-
Masciullo M., Santoro M., Modoni A., et al. Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up. J Inherit Metab Dis Sep 2010, 4:1-7. http://dx.doi.org/10.1007/s10545-010-9186-3.
-
(2010)
J Inherit Metab Dis Sep
, vol.4
, pp. 1-7
-
-
Masciullo, M.1
Santoro, M.2
Modoni, A.3
-
9
-
-
79957890647
-
Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis
-
Matsuoka K., Tamura T., Tsuji D., et al. Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis. Mol Ther 2011, 19:1017-1024.
-
(2011)
Mol Ther
, vol.19
, pp. 1017-1024
-
-
Matsuoka, K.1
Tamura, T.2
Tsuji, D.3
-
10
-
-
27844573882
-
Dystonia and Parkinsonism in GM1 type 3 gangliosidosis
-
Roze E., Paschke E., Lopez N., et al. Dystonia and Parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 2005, 20:1366-1369.
-
(2005)
Mov Disord
, vol.20
, pp. 1366-1369
-
-
Roze, E.1
Paschke, E.2
Lopez, N.3
-
11
-
-
34548373540
-
Chromatographic separation of human brain gangliosides
-
Svennerholm L. Chromatographic separation of human brain gangliosides. J Neurochem 1963, 10:613-623.
-
(1963)
J Neurochem
, vol.10
, pp. 613-623
-
-
Svennerholm, L.1
|
